The use of biological toxins or infectious agents such as bacteria, viruses, insects, and fungi with the intent to kill, harm or incapacitate humans, animals or plants as an act of war. Biological weapons (often termed “bio-weapons”, “biological threat agents”, or “bio-agents”) are living organisms or replicating entities ( i.e. viruses, which are not universally considered “alive”). Entomological (insect) warfare is a subtype of biological warfare.
Offensive biological warfare is prohibited under customary international humanitarian law and several international treaties. In particular, the 1972 Biological Weapons Convention (BWC) bans the development, production, acquisition, transfer, stockpiling and use of biological weapons. Therefore, the use of biological agents in armed conflict is a war crime. In contrast, defensive biological research for prophylactic, protective or other peaceful purposes is not prohibited by the BWC.
The official narrative is that a “bioterrorist” attack is something we need to be prepared for. Preparing for “pandemics” might be a test case for a more severe “bioterrorist” attack and thus it is necessary for us to do gain-of-function research only as a means of extraordinary precaution!
“The SARS-CoV-2 coronavirus features a so-called furin cleavage site (FCS), which makes the virus more infectious and virulent than it would otherwise be. Such an FCS is not known in any other SARS-like coronavirus, but it is often inserted as part of gain-of-function studies in virus research. However, similar FCS are known to occur in non-SARS-like coronaviruses, hence a natural origin cannot be excluded based on this. The furin cleavage site found in SARS-CoV-2 uses an arginine (amino acid) double codon, which is rather rare in natural coronaviruses, but quite common in engineered viruses used in lab experiments (…)”
According to researcher Larry Romanoff, “A US Army operating manual from 1956 stated explicitly that biological and chemical warfare were an integral operating portion of US military strategy, were not restricted in any way, and that Congress had given the military “First Strike” authority on their use. In 1959, an attempt by Congress to remove this first-strike authority was defeated by the White House and bio-chemical weapons expenditures increased from $75 million to almost $350 million.”
In over 200 cases the US tested bioweapons on their own citizens, according to ‘official’ news in the commercially-controlled media. Preparations overlap with “Terrorism/Preparation” since Anthrax was used in a false flag event and Pandemic/Preparation as the proposed solution is pre-emptive development and large scale funding of new (genetically modified) vaccines.
The United States operates a high number of level 3 and 4 labs worldwide. Accidents and carelessness on the side management shows, that it is not possible to operate these labs, even those with the highest security level, safely all the time. Especially notorious is the Plum Island bio lab near Long island. It was operated only as a biosafety level 3 lab, but it stands as an well documented example for technical and administrative problems that these facilities face. The research facility at Fort Detrick was shut down by the CDC in July 2019, citing failure to follow local procedures, lack of periodic recertification training for workers in the biocontainment laboratories and problems with the wastewater decontamination system.
The only such facility in mainland China is the Wuhan Institute of Virology of the Chinese Academy of Sciences, 8.6 miles from the Huanan Seafood Wholesale Market which the World Health Organization linked to the first reported cluster of Covid-19 patients, 44 people who became unwell with pneumonia of unknown cause, at the start of what was then referred to as the Wuhan coronavirus outbreak, later the 2020 coronavirus pandemic. Some have even linked the origin of the Covid-19 bioweapon to the Ukraine.
Georgia is a testing ground for bioweapons
The Lugar Center is the Pentagon bio laboratory in Georgia. It is located just 17 km away from the US Vaziani military airbase in the capital Tbilisi. Tasked with the military program are biologists from the US Army Medical Research Unit-Georgia (USAMRU-G) along with private contractors. The Bio-safety Level 3 Laboratory is accessible only to US citizens with security clearance. They are accorded diplomatic immunity under the 2002 US-Georgia Agreement on defense cooperation.
The USA-Georgia agreement accords diplomatic status to the US military and civilian personnel (including diplomatic vehicles), working on the Pentagon program in Georgia.
Information obtained from the US federal contracts registry clarifies some of the military activities at The Lugar Center – among them research on bio- agents (anthrax, tularemia) and viral diseases (e.g. Crimean-Congo Hemorrhagic Fever), and the collection of biological samples for future experiments.
Pentagon contractors produce bio agents under diplomatic cover
The Defense Threat Reduction Agency has outsourced much of the work under the military program to private companies, which are not held accountable to Congress, and which can operate more freely and move around the rule of law.
US civilian personnel performing work at The Lugar Center have also been given diplomatic immunity, although they are not diplomats. Hence, private companies can perform work, under diplomatic cover, for the US government without being under the direct control of the host state – in this case the Republic of Georgia. This practice is often used by the CIA to provide cover for its agents.
Three private American companies work at the US bio-laboratory in Tbilisi – CH2M Hill, Battelle and Metabiota. In addition to the Pentagon, these private contractors perform biological research for the CIA and various other government agencies.
CH2M Hill has been awarded $341.5 million DTRA contracts under the Pentagon’s program for bio-laboratories in Georgia, Uganda, Tanzania, Iraq, Afghanistan, South East Asia. Half of this sum ($161.1 million), being allocated to The Lugar Center, under the Georgian contract.
According to CH2M Hill, the US Company has secured biological agents and employed former bio warfare scientists at The Lugar Center. These are scientists who are working for another American company involved in the military program in Georgia – Battelle Memorial Institute.
Battelle as a $59 million subcontractor at Lugar Center has extensive experience in research on bio-agents, as the company has already worked on the US Bio-weapons Program under 11 previous contracts with the US Army (1952-1966).
The private company performs work for the Pentagon’s DTRA bio laboratories in Afghanistan, Armenia, Georgia, Uganda, Tanzania, Iraq, Afghanistan and Vietnam. Battelle conducts research, development, testing, and evaluation using both highly toxic chemicals and highly pathogenic biological agents for a wide range of US government agencies. It has been awarded some $2 billion federal contracts in total and ranks 23 on the Top 100 US government contractors list.
It all began with Project Clear Vision. The studies tied to this have been cleansed and published by the “on the make” academics and scientists who took the CIA’s cash and turned off their common sense and professional ethics.
Top Secret Experiments
Battelle has operated a Top Secret Bio laboratory (National Biodefense Analysis and Countermeasures Center – NBACC) at Fort Detrick, Maryland under a US Department of Homeland Security (DHS) contract for the last decade. The company has been awarded a $344.4 million federal contract (2006 – 2016) and another $17.3 million contract (2015 -2026) by DHS.
Amongst the secret experiments, performed by Battelle at NBACC, are: Assessment of powder dissemination technology ; Assessment of hazard posed by aerosolized toxins and Assessment of virulence of B. Pseudomallei (Meliodosis) as a function of aerosol particle in non-human primates. Melioidosis has the potential to be developed as a biological weapon, hence, it is classed as a category B. Bioterrorism Agent. B. Pseudomallei was studied by the US as a potential bioweapon in the past.
Amongst them to characterize classical, emerging and genetically engineered pathogens for their BTA (biological threat agent) potential; assess the nature of nontraditional, novel and non-endemic induction of disease from potential BTA and to expand aerosol-challenge testing capacity for non-human primates.
Tularemia, also known as Rabbit Fever, is classified as a bioterrorism agent and was developed in the past as such by the US. However, the Pentagon’s research on tularemia continues, as well as on possible vectors of the bacteria such as ticks and rodents which cause the disease.
The DTRA has launched a number of projects on Tularemia along with other especially dangerous pathogens in Georgia. Especially Dangerous Pathogens (EDPs), or select agents, represent a major concern for the public health globally.
These highly pathogenic agents have the potential to be weaponized with proof of their military importance seen through the following Pentagon projects: Epidemiology and Ecology of Tularemia in Georgia (2013-2016) (60 000 vectors were collected for strain isolates and genome research); Epidemiology of Human Tularemia in Georgia and Human Disease Epidemiology and Surveillance of Especially Dangerous Pathogens in Georgia (study of select agents among patients with undifferentiated fever and hemorrhagic fever/septic shock).
Tularemia is one of the bio-weapons that the US Army developed in the past.
Source: 1981 US Army Report
Pentagon bio-laboratories spread diseases in Ukraine
The DoD Defense Threat Reduction Agency (DTRA) has funded at least 11 bio-laboratories in the former Soviet Union Country Ukraine (The DoD later admitted to 46 military-funded labs in Ukraine alone), bordering on Russia. DTRA has allocated $80 million for biological research in Ukraine as of 30 July 2020, according to information obtained from the US Federal contracts registry. Tasked with the program is the US company Black &Veatch Special Projects Corp.
Another DTRA contractor operating in Ukraine is CH2M Hill. The American company has been awarded a $22.8 million contract (2020-2023) for the reconstruction and equipment of two biolaboratories: the State Scientific Research Institute of Laboratory Diagnostics and Veterinary-Sanitary Expertise (Kyiv ILD) and the State Service of Ukraine for Food Safety and Consumer Protection Regional Diagnostic Laboratory (Odesa RDL).
Continued on next page…